Treace provides technology that facilitates Lapiplasty bunion surgery and related midfoot deformities. The company recently ...

Why BTIG Upgraded the Shares Treace provides technology that facilitates Lapiplasty bunion surgery and related midfoot deformities. The company recently introduced a new technique called the ...

BTIG analyst Ryan Zimmerman upgraded Treace Medical (TMCI) to Buy from Neutral with a $16 price target The company has pivoted away from offering solely Lapiplasty, its leading technology ...

Why BTIG Upgraded the Shares Treace provides technology that facilitates Lapiplasty bunion surgery and related midfoot deformities. The company recently introduced a new technique called the ...

Treace Medical Concepts, Inc, a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that ...

BTIG analyst Ryan Zimmerman upgraded Treace Medical Concepts (TMCI – Research Report) to a Buy today and set a price target of $16.00. The company’s shares closed yesterday at $9.69.

Quite a few insiders have dramatically grown their holdings in Treace Medical Concepts, Inc. (NASDAQ:TMCI) over the past 12 months. An insider's optimism about the company's prospects is a positive ...